Table 2: Baseline demographics, comorbidities, and procedural characteristics.
|
Variable |
Value or Frequency (n = 931) |
|
Age (yrs) (median, IQR) |
65 (56-75) |
|
Age > 75 |
23.6% |
|
Caucasian |
92.5% |
|
Male |
68.1% |
|
Diabetes mellitus |
37.9% |
|
Hypertension |
83.7% |
|
Hyperlipidemia |
77.7% |
|
Smoking history |
52.2% |
|
Congestive heart failure |
11.1% |
|
Hypotension |
1.3% |
|
Previous myocardial infarction |
30.8% |
|
Previous CABG |
24.4% |
|
Peripheral vascular disease |
13.1% |
|
Previous angioplasty |
37.6% |
|
Hematocrit (%) (median, IQR) |
40 (37-43) |
|
Anemia |
26.9% |
|
Baseline serum Cr (mg/dl) (median, IQR) < 1.5 1.5-2.0 > 2.0 |
1.0 (0.9-1.2) 85.5% 11.7% 2.8% |
|
Baseline eGFR (ml/min 1.73 m2) (median, IQR) > 60 40-60 20-40 < 20 |
73 (57-89) 69.8% 20.8% 9.1% 0.2% |
|
Multivessel coronary artery disease |
60.6% |
|
Multivessel PCI |
23.7% |
|
Treated saphenous vein graft |
7.0% |
|
Intra-aortic balloon pump |
1.3% |
|
Contrast volume (ml) (median, IQR) |
193 (135-258) |
|
Contrast volume > 150 ml |
67.1% |
|
Pre-treated with intravenous sodium bicarbonate |
3.4% |
|
Pre-treated with N-acetycysteine |
15.2% |